Lobular Carcinoma In Situ

Surg Pathol Clin. 2018 Mar;11(1):123-145. doi: 10.1016/j.path.2017.09.009. Epub 2017 Dec 8.

Abstract

Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is approximately 9 to 10 times that of the general population. Classic LCIS diagnosed on core biopsy with concordant imaging and pathologic findings does not mandate surgical excision, and margin status is not reported. The identification of variant LCIS in a needle core biopsy specimen mandates surgical excision, regardless of radiologic-pathologic concordance. The presence of variant LCIS close to the surgical margin of a resection specimen is reported, and reexcision should be considered.

Keywords: CDH1; Core biopsy; E-cadherin; Pleomorphic lobular carcinoma in situ; Variant lobular carcinoma in situ; p120.

Publication types

  • Review

MeSH terms

  • Biopsy, Large-Core Needle
  • Breast Carcinoma In Situ / diagnosis*
  • Breast Carcinoma In Situ / diagnostic imaging
  • Breast Carcinoma In Situ / pathology*
  • Carcinoma, Lobular / diagnosis*
  • Carcinoma, Lobular / diagnostic imaging
  • Carcinoma, Lobular / pathology*
  • Disease Management
  • Female
  • Humans
  • Margins of Excision
  • Mastectomy, Segmental
  • Precancerous Conditions / diagnosis*
  • Precancerous Conditions / diagnostic imaging
  • Precancerous Conditions / pathology*
  • Precancerous Conditions / surgery
  • Unnecessary Procedures
  • Watchful Waiting